Board Moves.

89bio (NASDAQ: ETNB)

Appoints Martin Babler to the Board of Directors. Mr. Babler is the CEO at Alumis.

AdaptHealth (NASDAQ: AHCO)

Suzanne Foster named CEO and she is appointed to the Board of Directors. Ms. Foster is the Chief Executive Officer at AdaptHealth.

AEON Biopharma (NYSE: AEON)

Appoints Seongsoo Park to the Board of Directors. Mr. Park is the CEO at Daewoong Pharmaceutical.

Aquestive Therapeutics (NASDAQ: AQST)

Appoints Abigail Jenkins to the Board of Directors. Ms. Jenkins is the CEO at Gamida Cell.

Astria Therapeutics (NASDAQ: ATXS)

Appoints Sunil Agarwal to the Board of Directors. Mr. Agarwal is the former Chief Development Officer at Sana Biotechnology.

Autolus Therapeutics (NASDAQ: AUTL)

Appoints Michael Bonney and Ravi Rao to the Board of Directors. Mr. Bonney is the former Chair of the Board and Chief Executive Officer at Kaleido Biosciences and Mr. Rao is the Chief Medical Officer at Sitryx.

Bicycle Therapeutics (NASDAQ: BCYC)

Appoints Felix Baker to the Board of Directors. Mr. Baker is a Managing Member at Baker Bros Advisors.

CareDx (NASDAQ: CDNA)

John Hanna named CEO and he is appointed to the Board of Directors. Mr. Hanna is the former Chief Executive Officer at Apton Biosystems.

CARGO Therapeutics (NASDAQ: CRGX)

Appoints Kapil Dhingra to the Board of Directors. Mr. Dhingra is a Managing Member at KAPital Consulting LLC.

DaVita (NYSE: DVA)

Appoints Dennis Pullin to the Board of Directors. Mr. Pullin is the Chief Executive Officer at Virtua Health.

Elanco Animal Health (NYSE: ELAN)

Appoints Kathy Turner and Craig Wallace to the Board of Directors. Ms. Turner is the former Chief Marketing Officer at IDEXX Laboratories and Mr. Wallace is President at C.S. Wallace Investments & Strategy, LLC.

Enliven Therapeutics (NASDAQ: ELVN)

Appoints Lori Kunkel to the Board of Directors. Ms. Kunkel is the former Chief Medical Officer at Pharmacyclics.

‍

Hims & Hers Health (NYSE: HIMS)

Appoints Christopher Payne to the Board of Directors. Mr. Payne is the former President and Chief Operating Officer at DoorDash.

Kymera Therapeutics (NASDAQ: KYMR)

Appoints Felix Baker to the Board of Directors. Mr. Baker is a Managing Member at Baker Bros Advisors.

Nuvation Bio (NYSE: NUVB)

Appoints Jerry Wang and Min Cui to the Board of Directors. Mr. Wang is the Co-Founder and CEO at AnHeart and Mr. Cui is the Founder and Managing Director at Decheng Capital.

Recursion Pharmaceuticals (NASDAQ: RXRX)

Appoints Najat Khan to the Board of Directors. Ms. Khan is the Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.

Solventum (NYSE: SOLV)

Appoints Shirley Edwards to the Board of Directors. Ms. Edwards is a former Partner at EY.

Summit Therapeutics (NASDAQ: SMMT)

Appoints Mostafa Ronaghi to the Board of Directors. Mr. Ronaghi is a Co-Founder at Cellanome.

Vir Biotechnology (NASDAQ: VIR)

Appoints Norbert Bischofberger and Ramy Farid to the Board of Directors. Mr. Bischofberger is the CEO at Kronos Bio and Mr. Farid is the CEO at Schrodinger.

Zoetis (NYSE: ZTS)

Appoints Gavin Hattersley to the Board of Directors. Mr. Hattersley is the CEO at Molson Coors Beverage.

‍

Brookdale Senior Living (NYSE: BKD)

Guy Sansone and Marcus Bromley to leave the Board of Directors. Mr. Sansone is the Chair of the Board and Chief Executive Officer at H2 Health and Mr. Bromley is the former Chair of the Board and Chief Executive Officer at Gables Residential

Elevation Oncology (NASDAQ: ELEV)

Lori Hu resigns from the Board of Directors. Ms. Hu is a Managing Director at Vertex Ventures.

Evolus (NASDAQ: EOLS)

Robert Hayman and Simone Blank to leave the Board of Directors. Mr. Hayman is the Chief Executive Officer at Hayman Properties and Ms. Blank is the Founder at Dental Innovations.

Fortrea (NASDAQ: FTRE)

Betty Larson resigns from the Board of Directors. Ms. Larson is the Executive Vice President and Chief Human Resources Officer at Merck.

Mineralys Therapeutics (NASDAQ: MLYS)

Alexander Asam to leave the Board of Directors. Mr. Asam is an Advisor at HBM Partners.

NewAmsterdam Pharma NV (NASDAQ: NAMS)

Juliette Audet resigns from the Board of Directors. Ms. Audet has been named Chief Business Officer at NewAmsterdam Pharma.

Orthofix Medical (NASDAQ: OFIX)

Stuart Essig, James Hinrichs and Catherine Burzik to leave the Board of Directors. Mr. Essig is a Managing Director at Prettybrook, Mr. Hinrichs is a Co-Founder at Atmas Health and Ms. Burzik is the former CEO at Kinetic.

Savara (NASDAQ: SVRA)

Ricky Sun to leave the Board of Directors. Mr. Sun is a Managing Director at Bain Capital Life Sciences.

Trupanion (NASDAQ: TRUP)

Dan Levitan and Zay Satchu to leave the Board of Directors. Mr. Levitan is a Co-Founder at Levitan and Ms. Satchu is the Chief Veterinary Officer and Co-Founder at Bond Vet.

OPKO Health (NASDAQ: OPK)

Alexis Borisy to leave the Board of Directors. Mr. Borisy is a Biotechnology Entrepreneur Investor.

Quidelortho (NASDAQ: QDEL)

Douglas Bryant departs as CEO and resigns from the Board of Directors.

‍

Veracyte (NASDAQ: VCYT)

John Bishop retires from the Board of Directors. Mr. Bishop is the former CEO at Cepheid.

Verona Pharma (NASDAQ: VRNA)

Rishi Gupta resigns from the Board of Directors. Mr. Gupta is a Partner at OrbiMed Advisors.